Launch of SpectrAline™ Cartridges, for High-Performance MRR Sampling

BrightSpec launches SpectrAline™ Cartridges, a high-performance sample introduction solution designed to enhance MRR workflows.

Read the release on Business Wire here →

CHARLOTTESVILLE, Va. & BELLEFONTE, Pa.--(BUSINESS WIRE)--BrightSpec, the leader in Molecular Rotational Resonance (MRR) spectroscopy, today announced the launch of SpectrAline™ Cartridges, a new family of preconcentration columns co-developed with Restek Corporation, a globally recognized manufacturer of gas and liquid chromatography columns and accessories, sample preparation products, and analytical reference standards.

Designed and qualified jointly by BrightSpec and Restek scientists, SpectrAline Cartridges combine BrightSpec’s deep expertise in MRR applications with Restek’s manufacturing excellence to unlock higher sensitivity, more efficient sample loading, and access to previously challenging sample matrices. The companies have established a multi-year supply relationship under which Restek manufactures the cartridges and BrightSpec delivers them as a co-branded component of its MRR solution.

SpectrAline Cartridges are purpose-built to deliver robust, reproducible sample preconcentration for MRR workflows—maximizing the amount of analyte delivered to the measurement region while leveraging the specificity of MRR for molecular identification. The result is improved detection limits and reliable quantitation across a broader range of real-world samples.

“MRR performance depends not only on the spectrometer, but on how efficiently and cleanly molecules are introduced into the measurement region,” said Rick Gordon, CEO at BrightSpec. “SpectrAline Cartridges are engineered to load more sample, concentrate trace-level components, and enable MRR analysis from matrices that were previously difficult or impractical—directly translating to higher sensitivity and an expanded application space.”
Key benefits of SpectrAline Cartridges include:

• Enhanced sensitivity through MRR-optimized preconcentration, delivering more analyte to the gas phase and enabling confident detection of low-level components.
• Improved sample loading efficiency, supporting higher capacity and more consistent transfer of material into the MRR measurement region without complex preparation steps.
• Access to novel and challenging matrices, enabling MRR analysis of samples that traditionally require extensive cleanup or are poorly suited to direct measurement.
• Minimal sample preparation, supporting fast, routine structure identification and quantification workflows.

“For emerging analytical platforms to succeed, the consumables must be as reliable as the instrument itself,” said Jeanine Pippitt, Chief Commercial Officer. “Our role is to provide a standardized, scalable chemistry that users can depend on every day. Together with BrightSpec, we’re delivering not just a component, but a complete and sustainable workflow solution.”

SpectrAline Cartridges are fully compatible with BrightSpec’s current and upcoming MRR platforms and will be available for order beginning in June 2026.

To learn more about BrightSpec and the spectraMRR platform, please visit www.brightspec.com.

About BrightSpec

BrightSpec is the leading life science tools company commercializing instruments that harness the power of molecular rotational resonance (MRR) spectroscopy. MRR is an innovative approach to rapidly and definitively characterize the unique three-dimensional structure of small molecules, including all forms of structural and spatial isomers. BrightSpec offers a vertically integrated platform that includes quantum simulation, rotational spectrometers, data analysis tools, and automation with the goal of bringing this technology to the forefront of the applied sciences, including the pharmaceutical, chemical, and consumer goods industries.